Ignite Creation Date:
2025-12-24 @ 9:08 PM
Ignite Modification Date:
2026-05-29 @ 12:09 PM
Study NCT ID:
NCT00504504
Status:
COMPLETED
Last Update Posted:
2013-07-09
First Post:
2007-07-19
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Rituximab and ABVD for Hodgkin's Patients
Sponsor:
M.D. Anderson Cancer Center
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Lymphoma | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Hodgkin's Disease | View |
| None | Lymphoma | View |
| None | Rituximab | View |
| None | Rituxan | View |
| None | Adriamycin | View |
| None | Doxorubicin | View |
| None | Rubex | View |
| None | Bleomycin | View |
| None | Bleomycin sulfate | View |
| None | Blenoxane | View |
| None | BLM | View |
| None | Dacarbazine | View |
| None | DTIC | View |
| None | DTIC-Dome | View |
| None | Vincristine | View |
| None | Vinblastine | View |
| None | Vinblastine Sulfate | View |
| None | ABVD | View |
| None | ABVD Chemotherapy Treatment | View |